D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 31,843 569 World Ranking 6424 National Ranking 617

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of investigation include Internal medicine, Meta-analysis, Irritable bowel syndrome, Gastroenterology and Placebo. In Internal medicine, Alexander C. Ford works on issues like Surgery, which are connected to Number needed to treat. His work deals with themes such as Colitis, Incidence, Treatment outcome, Sex factors and Physical therapy, which intersect with Meta-analysis.

His Irritable bowel syndrome research incorporates elements of Gastrointestinal disease, Cognitive behavioral therapy, Abdominal pain and Etiology. His Gastroenterology research is multidisciplinary, incorporating perspectives in Odds ratio, Epidemiology, Cross-sectional study and Confidence interval. His Placebo research is multidisciplinary, relying on both Adverse effect, Rifaximin and Constipation.

His most cited work include:

  • Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis (1087 citations)
  • Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis (1087 citations)
  • The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review (567 citations)

What are the main themes of his work throughout his whole career to date?

Alexander C. Ford focuses on Internal medicine, Irritable bowel syndrome, Gastroenterology, Meta-analysis and Inflammatory bowel disease. His biological study spans a wide range of topics, including Placebo and Surgery. Alexander C. Ford has researched Irritable bowel syndrome in several fields, including Constipation, Intensive care medicine, Diarrhea, Colonoscopy and Abdominal pain.

His work on Helicobacter pylori and SeHCAT as part of general Gastroenterology research is frequently linked to In patient, bridging the gap between disciplines. His Meta-analysis research includes themes of Odds ratio, Relative risk, Confidence interval and Physical therapy. His Inflammatory bowel disease study incorporates themes from Comorbidity, Immunology, Depression and Anxiety.

He most often published in these fields:

  • Internal medicine (108.92%)
  • Irritable bowel syndrome (60.58%)
  • Gastroenterology (51.37%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (108.92%)
  • Irritable bowel syndrome (60.58%)
  • Meta-analysis (36.83%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Irritable bowel syndrome, Meta-analysis, Gastroenterology and Inflammatory bowel disease. Alexander C. Ford combines subjects such as Placebo, Depression and Anxiety with his study of Internal medicine. His studies in Irritable bowel syndrome integrate themes in fields like Constipation, Mood, Intensive care medicine, Abdominal pain and Comorbidity.

His Meta-analysis research is multidisciplinary, incorporating elements of Odds ratio, Relative risk, Confidence interval, Adverse effect and Quality of life. His Gastroenterology study combines topics in areas such as Reflux and Gastro-. His work carried out in the field of Inflammatory bowel disease brings together such families of science as Fibrosis, Inflammation, Female patient and Pharmacology.

Between 2019 and 2021, his most popular works were:

  • Helicobacter pylori eradication for the prevention of gastric neoplasia (56 citations)
  • Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis (38 citations)
  • Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis (38 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

Irritable bowel syndrome, Internal medicine, Meta-analysis, Relative risk and Adverse effect are his primary areas of study. His Irritable bowel syndrome study combines topics from a wide range of disciplines, such as Functional constipation, Epidemiology, Quality of life, Intensive care medicine and Comorbidity. His studies deal with areas such as Mood and Anxiety as well as Internal medicine.

His study in Meta-analysis is interdisciplinary in nature, drawing from both Odds ratio, Psychological intervention and Confidence interval. Alexander C. Ford interconnects Medical literature, Systematic review, Funnel plot, Contingency management and Physical therapy in the investigation of issues within Relative risk. The study incorporates disciplines such as Cancer, Gastroenterology, Helicobacter pylori, Incidence and Placebo in addition to Adverse effect.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Rebecca M. Lovell;Alexander C. Ford;Alexander C. Ford.
Clinical Gastroenterology and Hepatology (2012)

1916 Citations

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

Paul Moayyedi;Alexander Charles Ford;Nicholas J Talley;Filippo Cremonini.
Gut (2010)

904 Citations

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

Alexander C Ford;Nicholas J Talley;Brennan M R Spiegel;Amy E Foxx-Orenstein.
BMJ (2008)

785 Citations

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

Alexander Charles Ford;Nicholas J Talley;Philip S Schoenfeld;Eamonn Mm Quigley.
Gut (2009)

783 Citations

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.

Nicole C Suares;Alexander C Ford.
The American Journal of Gastroenterology (2011)

781 Citations

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.

Alexander C Ford;Eamonn M M Quigley;Brian E Lacy;Anthony J Lembo.
The American Journal of Gastroenterology (2014)

744 Citations

Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.

Alexander C Ford;William J Sandborn;Khurram J Khan;Stephen B Hanauer.
The American Journal of Gastroenterology (2011)

684 Citations

Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Khurram J Khan;Thomas A Ullman;Alexander C Ford;Maria T Abreu.
The American Journal of Gastroenterology (2011)

623 Citations

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

Alexander C Ford;Alexander C Ford;David Forman;Richard H Hunt;Yuhong Yuan.
BMJ (2014)

593 Citations

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Alexander C Ford;Paul Moayyedi;Brian E Lacy;Anthony J Lembo.
The American Journal of Gastroenterology (2014)

579 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alexander C. Ford

Nicholas J. Talley

Nicholas J. Talley

University of Newcastle Australia

Publications: 177

Magnus Simren

Magnus Simren

University of Gothenburg

Publications: 159

Eamonn Martin Quigley

Eamonn Martin Quigley

Cornell University

Publications: 107

Michael Camilleri

Michael Camilleri

Mayo Clinic

Publications: 94

Jan Tack

Jan Tack

KU Leuven

Publications: 92

Javier P. Gisbert

Javier P. Gisbert

Autonomous University of Madrid

Publications: 82

Paul Moayyedi

Paul Moayyedi

McMaster University

Publications: 75

William D. Chey

William D. Chey

University of Michigan–Ann Arbor

Publications: 68

Silvio Danese

Silvio Danese

Vita-Salute San Raffaele University

Publications: 56

Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

University of Lorraine

Publications: 56

Anthony Lembo

Anthony Lembo

Beth Israel Deaconess Medical Center

Publications: 54

Nayoung Kim

Nayoung Kim

Seoul National University Bundang Hospital

Publications: 51

John F. Cryan

John F. Cryan

University College Cork

Publications: 46

Timothy G. Dinan

Timothy G. Dinan

University College Cork

Publications: 45

Peter R. Gibson

Peter R. Gibson

Monash University

Publications: 45

Antonina Mikocka-Walus

Antonina Mikocka-Walus

Deakin University

Publications: 42

Trending Scientists

David S. Bonalle

David S. Bonalle

American Express (United States)

Tetsu Yonezawa

Tetsu Yonezawa

Hokkaido University

Yusuke Yamada

Yusuke Yamada

Osaka Metropolitan University

Carla M. Sgrò

Carla M. Sgrò

Monash University

Alasdair M. Cook

Alasdair M. Cook

University of Konstanz

Michael W. Berns

Michael W. Berns

University of California, Irvine

Paul Verkade

Paul Verkade

University of Bristol

A. Sarah Walker

A. Sarah Walker

University of Oxford

Renjie Dong

Renjie Dong

China Agricultural University

Patricia Limousin

Patricia Limousin

University College London

John G. Holmes

John G. Holmes

University of Waterloo

Massimo Casacchia

Massimo Casacchia

University of L'Aquila

Eric L. Matteson

Eric L. Matteson

Mayo Clinic

Emmanuel Bujold

Emmanuel Bujold

Université Laval

Ann Phoenix

Ann Phoenix

University College London

John Asher Johnson

John Asher Johnson

Harvard University

Something went wrong. Please try again later.